Evidera is evolving
Learn more
Evidera
  • Contact Us
  • Search
  • Who We Are
    • About Us
    • Executive Team
    • Who We Work With
    • Contact Us
  • What We Do
    • Real-World Evidence & Data Solutions
    • Non-Interventional Studies
    • Interventional Studies
    • Patient-Centered Research
    • Evidence Synthesis, Modeling & Communication
    • Strategic Development Consulting
    • Value & Access Consulting
    • Medical Writing
    • Implementation Science
  • Thought Leadership
    • Therapeutic Expertise
    • Investing in Innovation
    • Our Publication: The Evidence Forum
    • Publications
    • Resource Center
  • News & Events
    • Upcoming Conferences
    • Webinars
    • Newsroom
  • Careers

News Room

News Room
News & Events / News Room

Evidera’s Dr. Colleen A. McHorney Honored with NQF Innovation Challenge Award and Will Present During Webinar Series

January 12, 2018

Evidera Expands Patient-Centered Research Services

October 24, 2017

PPD and HealthCore Build on Existing Collaboration to Include PPD’s Evidera Business, Expanding Real-World Research Capabilities

August 28, 2017

PPD Creates Real-world Research and Market Access Business by Combining Medical Affairs Research Operations and Evidera

May 8, 2017

PPD Completes Evidera Acquisition, Strengthens Leadership in Real-World Research

September 6, 2016

Evidera Among the Top 50 Consulting Firms to Work for in Vault’s 2017 Ranking

August 30, 2016

Evidera to Join PPD, Creating a Global Leader in Real-World Research

August 9, 2016

Evidera welcomes Dr. Colleen A. McHorney as a Senior Research Leader in Outcomes Research

June 13, 2016

Evidera Congratulates the COPD Foundation on the Inclusion of the SGRQ in the New FDA COPD Draft Guidance

June 6, 2016

COPD Foundation and Evidera Awarded Best Personalized Medicine Advance or Application at the Clinical & Research Excellence (CARE) Awards

April 28, 2016

‹ 1 2 3 ›

©2025 Evidera, a PPD business. All Rights Reserved
  • Privacy Policy
  • Legal Notices
  • +1 301 654 9729 (US)
  • +44 (0) 208 576 5000 (EUR)
  • Site Map
  • Twitter
  • LinkedIn